Brightgene Bio-medical Technology Co Ltd Class A 688166
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 36.20
- Day Range
- CNY 35.29–36.66
- 52-Week Range
- CNY 17.81–46.88
- Bid/Ask
- CNY 35.44 / CNY 35.45
- Market Cap
- CNY 14.97 Bil
- Volume/Avg
- 10.9 Mil / 11.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- 84.46
- Price/Sales
- 12.65
- Dividend Yield (Trailing)
- 0.32%
- Dividend Yield (Forward)
- 0.32%
- Total Yield
- 0.31%
Company Profile
Brightgene Bio-medical Technology Co Ltd is a pharmaceutical company engaged in research, development and production of new drugs and high-end generic drugs. The company develops macrolides, peptides, polysaccharides, heterocycles, azoles, azines, phenyl ethers, tetracyclines, and production of non-pharmaceutical macrolides, peptides, polysaccharides, heterocycles, azoles, azines, benzene Ethers, tetracyclines.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,128
- Website
- http://www.bright-gene.com
Comparables
Valuation
|
Metric
|
688166
|
688076
|
603566
|
|---|---|---|---|
Price/Earnings (Normalized) | 84.46 | 67.40 | 56.77 |
Price/Book Value | 6.30 | 5.79 | 2.52 |
Price/Sales | 12.65 | 11.24 | 5.90 |
Price/Cash Flow | 48.30 | 46.75 | 28.45 |
Price/Earnings
688166
688076
603566
Financial Strength
|
Metric
|
688166
|
688076
|
603566
|
|---|---|---|---|
Quick Ratio | 1.32 | — | 2.52 |
Current Ratio | 1.78 | — | 3.00 |
Interest Coverage | 4.45 | — | — |
Quick Ratio
688166
688076
603566
Profitability
|
Metric
|
688166
|
688076
|
603566
|
|---|---|---|---|
Return on Assets (Normalized) | 3.66% | — | 3.63% |
Return on Equity (Normalized) | 7.68% | — | 4.33% |
Return on Invested Capital (Normalized) | 4.53% | — | 4.16% |
Return on Assets
688166
688076
603566
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Xknsfvrw | Lnl | $567.0 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Tljlvjd | Ljrwcl | $109.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Drwncnhs | Wfhdfq | $105.3 Bil | |
MRNA
| Moderna Inc | Cwzrqtq | Nnjz | $47.0 Bil | |
ARGX
| argenx SE ADR | Lywhmvjn | Ygzt | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Hflvhwws | Gsrxm | $22.1 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Gfyzgsbx | Jlrqtk | $19.0 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Hyxmwxsd | Lgcdlq | $15.5 Bil | |
RPRX
| Royalty Pharma PLC Class A | Trqmthcm | Htdrfh | $12.7 Bil | |
INCY
| Incyte Corp | Nhwlpfwq | Fzdypv | $12.0 Bil |